| Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades (vol 10, 1113, 2019) | |
| Chen, Hao; Chong, Wei; Wu, Qian; Yao, Yueliang; Mao, Min; Wang, Xin | |
| 刊名 | FRONTIERS IN IMMUNOLOGY
 |
| 2019 | |
| 卷号 | 10 |
| 关键词 | LRP1B melanoma NSCLC tumor mutation burden immunotherapy mutation signatures |
| DOI | 10.3389/fimmu.2019.01523 |
| URL标识 | 查看原文 |
| 公开日期 | [db:dc_date_available] |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4540901 |
| 专题 | 山东大学 |
| 作者单位 | 1.Shandong Univ, Qilu Hosp, Clin Epidemiol Unit, Jinan, Shandong, Peoples R China. 2.Tianjin Med Univ Canc Inst & Hosp, Natl Cl |
| 推荐引用方式 GB/T 7714 | Chen, Hao,Chong, Wei,Wu, Qian,et al. Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades (vol 10, 1113, 2019)[J]. FRONTIERS IN IMMUNOLOGY,2019,10. |
| APA | Chen, Hao,Chong, Wei,Wu, Qian,Yao, Yueliang,Mao, Min,&Wang, Xin.(2019).Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades (vol 10, 1113, 2019).FRONTIERS IN IMMUNOLOGY,10. |
| MLA | Chen, Hao,et al."Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades (vol 10, 1113, 2019)".FRONTIERS IN IMMUNOLOGY 10(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论